Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,759,000 | 6,711,000 | 9,201,000 | 11,832,000 | 8,521,000 |
| Marketable Securities | 7,000 | 11,000 | 28,000 | 47,000 | 1,440,000 |
| Receivables | 11,491,000 | 11,473,000 | 11,254,000 | 10,743,000 | 11,237,000 |
| Inventories | 4,055,000 | 3,833,000 | 3,579,000 | 3,172,000 | 3,396,000 |
| TOTAL | $28,852,000 | $26,488,000 | $28,463,000 | $30,364,000 | $29,100,000 |
| Non-Current Assets | |||||
| PPE Net | 4,943,000 | 4,931,000 | 4,935,000 | 4,893,000 | 4,958,000 |
| Investments And Advances | 288,000 | 257,000 | 241,000 | 235,000 | 244,000 |
| Intangibles | 95,086,000 | 97,068,000 | 99,595,000 | 100,451,000 | 103,851,000 |
| Other Non-Current Assets | 6,198,000 | 5,800,000 | 5,571,000 | 5,382,000 | 5,033,000 |
| TOTAL | $106,515,000 | $108,056,000 | $110,342,000 | $110,961,000 | $114,086,000 |
| Total Assets | $135,367,000 | $134,544,000 | $138,805,000 | $141,325,000 | $143,186,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,203,000 | 2,801,000 | 4,136,000 | 9,207,000 | 11,930,000 |
| Accounts payable and accrued liabilities | 27,036,000 | 24,789,000 | 25,402,000 | 23,505,000 | 22,543,000 |
| TOTAL | $32,239,000 | $27,590,000 | $29,538,000 | $32,712,000 | $34,473,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 55,812,000 | 59,292,000 | 59,135,000 | 60,399,000 | 61,002,000 |
| Other Non-Current Liabilities | 32,291,000 | 32,247,000 | 30,656,000 | 30,212,000 | 30,764,000 |
| TOTAL | $90,230,000 | $93,651,000 | $91,980,000 | $92,586,000 | $94,025,000 |
| Total Liabilities | $122,469,000 | $121,241,000 | $121,518,000 | $125,298,000 | $128,498,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,765,047 | 1,764,290 | 1,769,400 | 1,768,481 | 1,768,097 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 1,789,000 | 2,393,000 | 4,784,000 | 4,953,000 | 3,516,000 |
| Other shareholders' equity | -2,220,000 | -2,203,000 | -2,166,000 | -3,410,000 | -3,161,000 |
| TOTAL | $12,898,000 | $13,303,000 | $17,287,000 | $16,027,000 | $14,688,000 |
| Total Liabilities And Equity | $135,367,000 | $134,544,000 | $138,805,000 | $141,325,000 | $143,186,000 |